STONKWHISPER
← Back to Intel
Insider ActivityMLYS

Rodman David Malcom, Chief Medical Officer at Mineralys Therapeutics, Inc., sold $402K of MLYS

Updated Jun 19, 2026
Rodman David Malcom Chief Medical Officer
Mineralys Therapeutics, Inc. · $MLYS
$402K Total Value
14,056 Shares Traded
$28.5849 Price / Share
63,443 Shares Owned After
2026-05-13 Filing Date

Transaction Details

InsiderRodman David Malcom
TitleChief Medical Officer
CompanyMineralys Therapeutics, Inc.
TickerMLYS
Transaction TypeSale
Transaction Date2026-05-13
Shares Traded14,056
Price Per Share$28.5849
Total Value$402K
Filed Date2026-05-13
Accession Number0001672659-26-000027

Ownership Context

Shares Owned After Transaction63,443
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001672659-26-000027

Other Insider Trades — MLYS

Other Trades by Rodman David Malcom

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MLYS — Mineralys Therapeutics, Inc. →

Track MLYS insider activity in real time on The Wire →

Get alerts when Rodman David Malcom files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:11 UTC

Want real-time data? Access The Wire for live sentiment tracking.